Open Access Opinion Article ID: SJGGT-4-113

    First Treatment for Breast Cancer with certain Inherited Gene Mutation

    Sulaiman Naseer*

    The U.S. Food and Drug Administration approved use of Lynparza (olaparib tablets) treat certain types of  breast cancer that have spread (metastasized) and whose tumors have a specific inherited (germline) genetic mutation, making it the first drug in its class (PARP inhibitor) approved to treat breast cancer.


    Published on: Feb 15, 2018 Pages: 1-1

    Full Text PDF Full Text HTML DOI: 10.17352/sjggt.000013
    Get Citation Base Search Scilit OAI-PMH ResearchGate GrowKudos CrossMark

    Global Views

    Case Reports

    Peertechz Tweets

    Pinterest on SJGGT